EPO and Stroke: Since EPO can cross the blood–brain barrier (BBB) (Brines et al., 2000), peripheral administration of EPO has been investigated as a potential neuroprotective treatment in neurological disease models for stroke (Zhang et al., 2006), multiple sclerosis (MS) (Cervellini et al., 2013), and ALS (Grunfeld et al., 2007).